Tell a friend
(Mandatory)
(Mandatory)
(Mandatory)
(Mandatory)

EPF acknowledgement of Financial Support 2012

EPF wishes to thank the following donors for their support:

% of total income
Operational work programme
European Commission (Executive Agency for Health and Consumers) 562,012.21 40.3%
GSK        30,000.00
2.2%
MSD        30,000.00
2.2%
Novartis        30,000.00
2.2%
Pfizer        25,000.00
1.8%
Gilead        15,000.00
1.1%
Project portfolio and capacity building programme
GSK (30.000€ received in 2011 and 50.000€ advance on 2013 activities)        80,000.00
5.7%
Novartis (20.000€ received in 2013 for the eHealth conference)        50,000.00
3.6%
Sanofi-Aventis        40,000.00
2.9%
AMGEN        35,000.00
2.5%
Janssen Pharma        30,000.00
2.2%
Medtronic Foundation        30,000.00
2.2%
Eli Lilly        20,000.00
1.4%
Sanofi-Pasteur MSD        20,000.00
1.4%
Microsoft Corporation XC        15,276.00
1.1%
Hoffmann-La Roche        15,000.00
1.1%
Baxter World Trade        10,000.00
0.7%
CSL Behring Biotherapies        10,000.00
0.7%
Laboratoires Servier        10,000.00
0.7%
Philips        10,000.00
0.7%
The European Patients' Academy on Therapeutic Innovation Public Private Partnership (EUPATI)
Innovative Medicine Initiative (IMI JU) contribution      105,129.19
7.5%
Industry consortium (UCB, Amgen, Genzyme, VFA, AZ, Novonordisk, Bayer, Merck, Janssen, GSK, Chiesi, Hoffmann, Lilly, Novartis, Esteve)        62,045.37
4.4%
Note: the income provided represents EPF's share in the consortium's contributions to the project only.
EPF wishes to thank the European Commission for its support in 2012 in relation to EPF's role in the following projects:
Interquality         55,488.17
4.0%
Chain of Trust        42,235.42
3.0%
Sustains        25,350.64
1.8%
Joint Action Patient Safety & Quality Care        21,970.24
1.6%
Memberships and other income
15,551.21
1.1%
Total income  1,395,058.45 100.0%
Accruals and deferrals (1)    -208,466.00
Total income net of adjustments  1,186,592.45
(1) In accordance with generally accepted accounting principles, any funding received in-year is subject to accrual and deferral adjustments proportionate to the level of resources assigned to pluriannual activities and projects. In 2012, the effect of this method was a reduction in total income by € 208.466, of which € 142.642 corresponded to private sector donations.